Skip to main content

Effect of Low Dosage of Naloxone on Clonidine- Induced Changes in Blood Pressure, Catecholamines, Renin, and Aldosterone in Essential Hypertension

  • Conference paper
Opioid Peptides and Blood Pressure Control
  • 69 Accesses

Abstract

In spontaneously hypertensive rats opioid receptor blockade by naloxone reversed the antihypertensive effect of clonidine (Farsang and Kunos 1979, Farsang et al. 1980; Kunos et al. 1981; Baum and Becker 1982; Ramirez-Gonzales et al. 1983). A similar effect of naloxone was reported in normotensive rats by Bennet et al. (1982), whereas Farsang et al. (1980) found that naloxone was without effect. In man naloxone was without effect on the clonidine-induced fall in blood pressure in normotensive individuals (Watkins et al. 1980). In hypertensive man some investigators found that naloxone reduced the fall in blood pressure induced by clonidine (Farsang et al. 1982, 1984a, c), but other investigators were unable to confirm these results (Rogers and Cubeddu 1983; Pedrinelli et al. 1983; Mathias et al. 1985; Levin et al. 1986).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Baum T, Becker FT (1982) Alpha-adrenergic and 5-hydroxytryptaminergic receptor stimulants as new antihypertensive drugs, with observations on involvement of opiate receptors. Clin Exp Hypertens [A] 4 (1-2): 235 - 248

    Article  CAS  Google Scholar 

  • Bennett DA, DeFeo JJ, Elko EE, Lai H (1982) Naloxone-induced reversal of Clonidine, but not hydralazine, hypotension. Drug Dev Res 2: 175 - 179

    Article  CAS  Google Scholar 

  • Bramnert M, Hökfelt B (1983) Failure of naloxone to reduce the Clonidine induced reduction of blood pressure and plasma noradrenaline in patients with essential hypertension. Acta Physiol Scand 118: 379 - 383

    Article  PubMed  CAS  Google Scholar 

  • Cohen EL, Grim CE, Conn JW, Blough WM Jr, Guyer RB, Kem DC, Lucas CP (1971) Accurate and rapid measurement of plasma renin activity by radioimmunoassay. J Lab Clin Med 77: 1025 - 1038

    PubMed  CAS  Google Scholar 

  • Farsang C, Kunos G (1979) Naloxone reverses the antihypertensive effect of Clonidine. Br J Pharmacol 67: 161 - 164

    PubMed  CAS  Google Scholar 

  • Farsang C, Ramirez-Gonzalez MD, Mucci L, Kunos G (1980) Possible role of an endogenous opiate in the cardiovascular effect of central alpha adrenoreceptor stimulation in spontaneously hypertensive rats. J Pharmacol Exp Ther 214: 203 - 208

    PubMed  CAS  Google Scholar 

  • Farsang C, Kapocsi J, Juhasz I, Kunos G (1982) Possible involvement of an endogenous opioid in the antihypertensive effect of Clonidine in patients with essential hypertension. Circulation 66: 1268 - 1282

    Article  PubMed  CAS  Google Scholar 

  • Farsang C, Vajda L, Kapocsi J, Malisak Z, Alföldi S, Varga K, Juhasz I, Kunos G (1983) Diurnal rhythm of beta-endorphin in normotensive and hypertensive patients: the effect of Clonidine. J Clin Endorinol Metab 56: 865 - 867

    Article  CAS  Google Scholar 

  • Farsang C, Varga K, Vajda L, Alföldi S, Kapocsi J (1984a) Effects of Clonidine and guanfacine in essential hypertension. Clin Pharmacol Ther 36: 588 - 594

    Article  PubMed  CAS  Google Scholar 

  • Farsang C, Varga K, Vajda L, Kapocsi J, Balas-Eltes A, Kunos G (1984b) Beta-endorphin contributes to the antihypertensive effect of Clonidine in a subset of patients with essential hypertension. Neuropeptides 4: 293 - 302

    Article  PubMed  CAS  Google Scholar 

  • Farsang C, Kapocsi J, Vajda L, Varga K, Malisak Z, Fekete M, Kunos G (1984c) Reversal by naloxone of the antihypertensive action of Clonidine: involvement of the symphathetic nervous system. Circulation 69: 461 - 467

    Article  PubMed  CAS  Google Scholar 

  • Farsang C, Kapocsi J, Varga K, Vajda L, Balas-Eltes A, Kunos G (1985) Beta-endorphin and essential hypertension: importance of the clonidine-naloxone interaction. Acta Physiol Hung 65: 217 - 226

    PubMed  CAS  Google Scholar 

  • Goodfrey K (1985) Statistics in practice: comparing the means of levels of several groups. N Engl J Med 313: 1450 - 1456

    Article  Google Scholar 

  • Haber E, Koerner T, Page LB, Kliman B, Purnode A (1969) Application of a radioimmunoassay for angiotensin I to the physiological measurements of plasma renin activity in normal human subjects. J Clin Endocrinol Metab 29: 1349 - 1355

    Article  PubMed  CAS  Google Scholar 

  • Kunos B, Farsang CA, Ramirez-Gonzales MD (1981) Beta-endorphin: possible involvement in the antihypertensive effect of central alpha-receptor activation. Science 211: 82 - 84

    Article  PubMed  CAS  Google Scholar 

  • Levin ER, Sharp B, Weber MA, Drayer JIM (1986) Endogenous opioid peptides: do they mediate the acute antihypertensive action of Clonidine in humans? Horm Res 23: 193 - 199

    Article  PubMed  CAS  Google Scholar 

  • Mathias CJ, da Costa DF, Cleary JC, Peart S (1985) Naloxone does not affect the cardiovascular, sedative or neurohormonal effects of Clonidine in normal and hypertensive man. J Hypertension 3: s77 - s79

    CAS  Google Scholar 

  • Ogihara T, Inuma K, Nishi K, Arakawa Y, Takagi A, Kurata K, Miyai K, Kumahara Y (1977) A non- chromatographic non-extraction radioimmunoassay for serum aldosterone. J Clin Endocrinol Metab 45: 726 - 731

    Article  PubMed  CAS  Google Scholar 

  • Pedrinelli R, Bernini G, Vivaldi MS, Salvetti A (1983) Interaction between central alpha-adrenergic stimulation and endogenous opioids in hypertensive man. J Hypertension 1: 243 - 245

    Google Scholar 

  • Peuler JD, Johnson G A (1977) Simultaneous single isotope radioenzymatic assay of plasma norepinephrine, epinephrine and dopamine. Life Sei 21: 625 - 636

    Article  CAS  Google Scholar 

  • Ramirez-Gonzales MD, Tchakarov L, Garcia RM, Kunos G (1983) Beta-endorphin acting on the brainstem is involved in the antihypertensive action of Clonidine and alpha-methyldopa in rats. Circ Res 53: 150 - 157

    Google Scholar 

  • Rogers JF, Cubeddu LX (1983) Naloxone does not antagonize the antihypertensive effect of Clonidine in essential hypertension. Clin Pharmacol Ther 34: 68 - 73

    Article  PubMed  CAS  Google Scholar 

  • Watkins J, Fitzgerald G, Zamboulis C, Brown MJ, Dollery CT (1980) Absence of opiate and histamine H2 receptor-mediated effects of Clonidine. Clin Pharmacol Ther 28: 605 - 610

    Article  PubMed  CAS  Google Scholar 

  • Yasunari K, Kanayama Y, Kohno M, Murakawa K, Kawarabayashi T, Takeda T, Kotsugai N, Sato K (1985) Central alpha-activation by Clonidine reduces plasma level of beta-endorphin in patients with essential hypertension. Life Sci 37: 1461 - 1467

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1988 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Bramnert, M., Hökfelt, B. (1988). Effect of Low Dosage of Naloxone on Clonidine- Induced Changes in Blood Pressure, Catecholamines, Renin, and Aldosterone in Essential Hypertension. In: Stumpe, K.O., Kraft, K., Faden, A.I. (eds) Opioid Peptides and Blood Pressure Control. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-73429-8_30

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-73429-8_30

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-18935-0

  • Online ISBN: 978-3-642-73429-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics